Concepedia

Amy B. Heptinstall

AB

Statistics

Publications

4

Citations

69

H-Index

4

Active since

2018

Affiliations

Newcastle University(Current)

Amy B. Heptinstall is an author at Newcastle University specializing in drug design, drug discovery, and pharmacy.

Publications per year

2018–2022

4

Publications

4

Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38α and BRD4

Stephanie M. Myers, Duncan C. Miller, Lauren Molyneux et al. · European Journal of Medicinal Chemistry · 2019 · 22 citations · Full text

, , +8

Identification of a novel ligand for the ATAD2 bromodomain with selectivity over BRD4 through a fragment growing approach

Duncan C. Miller, Mathew P. Martin, Santosh Adhikari et al. · Organic & Biomolecular Chemistry · 2018 · 17 citations · Full text

, , +15

An Alkynylpyrimidine-Based Covalent Inhibitor That Targets a Unique Cysteine in NF-κB-Inducing Kinase

Islam Al-Khawaldeh, Mohammed J. Al Yasiri, Gregory G. Aldred et al. · Journal of Medicinal Chemistry · 2021 · 16 citations · Full text

, , +14

Mapping Ligand Interactions of Bromodomains BRD4 and ATAD2 with FragLites and PepLites─Halogenated Probes of Druglike and Peptide-like Molecular Interactions

Gemma Davison, Mathew P. Martin, Shannon Turberville et al. · Journal of Medicinal Chemistry · 2022 · 14 citations · Full text

, , +17

1–4 of 4